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Abstract
Introduction. Preoperative diagnosis of GIST is an important factor in the management. However, due to the rarity of the case, there is a
controversy about the accuracy of CT scan as an accurate diagnostic tool. Therefore, a systematic review is required to find out the answer.
Method. A review was conducted to find out evidence of the highest level regarding the accuracy of CT scan as a diagnostic modality of GIST.
The study addressed to find out the sensitivity, specificity, positive and negative predictive values. A literature search carried out in database sites
i.e. PubMed, ClinicalKey, ScienceDirect, and Cochrane using keywords “gastrointestinal stromal tumor” OR “GIST” AND “ultrasound” OR
“CT scan” OR “MRI” AND “diagnostic” OR “imaging”. Systematic reviews, RCTs, cohort study, case report or series, studies in adults, published
within the last ten years, and availability in full text were included. Correspondence, editorial, or commentary, and no histopathology data were
excluded. The articles were critically appraised. The review proceeded in accordance with PRISMA.
Results. Twelve studies were analyzed in the study. The sensitivity of CT scan was in range of 77.26–94.9%, specificity 77.2–100%, PPV 74.38–
100%, and NPV 68.32–81.2%. CT scan was found to be the modality of choice in establishing the diagnosis of GIST. Central necrosis,
heterogenous enhancement, cavitation without lymphadenopathy were the features represented by CT scan.
Conclusion. CT scan is the modality of choice in establishing diagnosis of uncomplicated GIST, with sensitivity and specificity of 94.9% and
100%, respectively. Other modalities were considered in advanced or GIST with metastasis.
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Introduction
Gastrointestinal Stromal Tumor (GIST) is a rare soft tissue sarcoma
comprising 1–3% of all gastrointestinal cancers and 5,7% of all
sarcomas.1,2,3 However, GIST is the most common mesenchymal
tumor of the gastrointestinal tract with incidence 900 cases per year
in United Kingdom.1,4 The highest incidence found in those of 50–60
years old and predominantly in males.4,5 This tumor may be found
along the GI tract, mostly in the gaster (60–70%), small intestines
(20–30%), and occasionally in the esophagus, mesenteries,
omentum, colon, and rectum (5–8%).4,6 The most common clinical
manifestation is GI bleeding from mucosal ulcers, that manifested as
hematemesis, hematochezia, melena, or anemia in those with occult
bleeding.7 Other signs and symptoms may include nausea, vomiting,
abdominal pain, weight loss, abdominal distension, intestinal
obstruction, and dysphagia in patients with esophageal GIST.8
Clinical manifestations were found in vary depends on tumor size and
location. In small sized tumor, the manifestations may be absent;
tumors are unintentionally found on radiologic examination or
surgical procedure for any other condition.
Nowadays, surgery remains the main modality in the management of
GIST. Recent studies showed that molecular targeted therapeutic
agents such as imatinib mesylate may be benefit, though infrequent,
and is indicated in unresectable or metastasized GIST.9,10 Though in
small sized tumor, GIST has a great potential to a malignancy.
Thereby, an effort addressed to differentiate GIST to other

subepithelial tumors accurately is crucial to decide management plan
and prognosis.11 To date, diagnosis of GIST is established by imaging
as surgical biopsy for specimen carries on the risk of tumor rupture
and tumor seeding along the tract of biopsy.12 CT scan is reported to
have a superiority in differentiating GIST to non–GIST as CT
provides accurate tumor size, location, and tumor heterogeneity.13
There’s a group of experts believed that the accuracy of CT scan to
be superior in diagnosing GIST, while as in contrast others
recommend other modalities. Thus, a study aimed to find out
evidence of the highest level.
Method
This systematic review conducted in accordance with meta–analysis
report algorithm arranged by preferred reporting items for systematic
review and meta–analysis protocols (PRISMA). Literature search
was conducted in online database sites (PubMed and Cochrane)
using keywords “gastrointestinal stromal tumor” OR “GIST” AND
“ultrasound” OR “CT scan” OR “MRI” AND “diagnostic” OR
“imaging”. Systematic reviews, RCTs, cohort study, case report or
series, studies in adults, publication within the last ten years, and
availability in full text were included. Correspondence, editorial, or
commentary, and no histopathology data were excluded. The articles
were critically appraised. The study addressed to find out the
sensitivity, specificity, positive and negative predictive values. The
use of MRI, USG, and PET scan to diagnose GIST. Important data
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obtained from every article were summarized in the tables of data
extraction.
Results
On literature search, there were a total of 719 studies found. On
filtering, there were 79 articles found. Next, 67 articles were excluded
due to inability in fulfillment of the criteria such as the absence of
histopathology result which is the gold standard of diagnosis of GIST,
and pediatric. Thus, a total of 12 studies enrolled to the study.

Figure 1. Algorithm in literature search.

Discussion
Gastrointestinal stromal tumor is a rare one. CT scan is the first
diagnostic modality of choice on GIST.14 A study Lee et al showed
that the features of CT scan features compared to surgical findings,
metastasis, Hounsfield Unit value, contrast effect, complication,
tumor size and location from the pathologic confirmed the GIST.15 In
this study out of 12, a total 6 studies were evaluating the use of CT
scan in establishing the diagnosis of GIST, two studies focused on the
use of ultrasound, two studies focused on the use of FDG–PET/CT,
and a study focused on the use of CT scan compared to endoscopy.
Most of the studies showed that GIST found in the stomach (70%),
in the mesenteries of the jejunum (30%), and extraluminal GIST
(70%). Tumor margins are well defined in 76% subjects. Contrast CT
scan showed homogenous and heterogeneous changes at 13 and 4
Hounsfield Unit. The average result of Hounsfield unit is 30.41+
5.01.14,15
Other studies have shown the efficacy of CT scan as Baheti et al did
in 2015 who compared the sensitivity and specificity of CT scan to
other diagnostic modalities.16 On their study is shown that CT scan
provide a same sensitivity and specificity compared to ultrasound and
Doppler ultrasound. Cai et al (2015) who analyzed subjects
diagnosed with GIST focused on clinical signs, physical examination
and CT scan as variables on the study showed CT scan has a good
sensitivity and specivicity.10 Miedzybrodzki et al (2017) found CT
scan sensitivity and specificity is 89% and 100%, respectively.17
Choi et al (2014) found high sensitivity of 94.9% and specificity of
93.8%.18 Study by Horton et al (2014) also showed that CT scan is
the first choice of diagnostic modality.19

appearance and increased peak–intensity on the ultrasonography.
This wash–in appearance reduces the image quality provided
because of the image stored in the previous process on the monitor
screen. The increased peak–intensity is the increased of maximum
contrast on ultrasound devices let the image looks not alike the real
that need a reinterpretation on the reading. Study of Sun et al showed
endoscopic ultrasound was the best follow up method to detect
postoperative complications.21 Miedzybrodzki et al (2012) found the
use of endoscopy in diagnosing GIST provide the sensitivity of 82%,
specificity of 100%, positive predictive value of 100%, and negative
predictive value of 58%.17 Stroszczynski et al (2005) found MRI was
the best method to detect metastasis of GIST.22
CT imaging showed the characteristics of CT such as central
necrosis, heterogeneous enhancement, cavitation that provides gas–
like feature within the tumor, and the absence of enlarged lymph
nodes. While as MRI provides a better feature to detect invasion and
metastasis due to the superiority of MRI in evaluation of soft tissue.
The delineation of spatial relationship to surrounding structures
denoting tumor extension. The multiplanar view provides by MRI
may shows the origin of tumor, relationships to other organ and large
blood vessels.
Selection of the modality to establish GIST is influenced by many
factors. The anatomical site of tumor is an important one. In the
anatomical region where the soft tissue is predominance, MRI and
ultrasound provide a better imaging.23 In the area where the tumor is
suspected to be in the posterior, then the endoscopic ultrasound
referred to be superior.20 A typical tumor response determined based
on the previous established criteria, including changes in tumor size
and decreased number of intra–tumoral blood vessels. These changes
were measured as the therapeutic response. A study of Abbeele et al
showed important markers/proxies of the tumor metabolic changes.
Decreasing tumor metabolic activity precedes the decrease of tumor
size followed with the increased quality of life.13
Conclusion
CT scan is a diagnostic modality for investigation uncomplicated
GIST with high sensitivity and specificity (94.9% and 100%,
respectively). Other modalities to be considered in advanced or with
metastasis.
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